PL3137067T3 - Cytykolina poprawiająca funkcje motoryczne - Google Patents

Cytykolina poprawiająca funkcje motoryczne

Info

Publication number
PL3137067T3
PL3137067T3 PL15786597T PL15786597T PL3137067T3 PL 3137067 T3 PL3137067 T3 PL 3137067T3 PL 15786597 T PL15786597 T PL 15786597T PL 15786597 T PL15786597 T PL 15786597T PL 3137067 T3 PL3137067 T3 PL 3137067T3
Authority
PL
Poland
Prior art keywords
citicoline
motor function
improve motor
improve
function
Prior art date
Application number
PL15786597T
Other languages
English (en)
Polish (pl)
Inventor
Deborah Yurgelun-Todd
Perry Renshaw
Miho Takada
Takeshi Ikeda
Masahiko Morita
Original Assignee
Kyowa Hakko Bio Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Bio Co., Ltd. filed Critical Kyowa Hakko Bio Co., Ltd.
Publication of PL3137067T3 publication Critical patent/PL3137067T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PL15786597T 2014-04-30 2015-04-30 Cytykolina poprawiająca funkcje motoryczne PL3137067T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461986502P 2014-04-30 2014-04-30
PCT/IB2015/053178 WO2015166463A1 (en) 2014-04-30 2015-04-30 Administration of citicoline to improve cognitive performance, attentional performance, and motor function
EP15786597.3A EP3137067B1 (en) 2014-04-30 2015-04-30 Citicoline to improve motor function

Publications (1)

Publication Number Publication Date
PL3137067T3 true PL3137067T3 (pl) 2022-06-27

Family

ID=54358252

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15786597T PL3137067T3 (pl) 2014-04-30 2015-04-30 Cytykolina poprawiająca funkcje motoryczne

Country Status (8)

Country Link
US (2) US11583546B2 (enExample)
EP (1) EP3137067B1 (enExample)
JP (1) JP6584430B2 (enExample)
AU (1) AU2015254865B2 (enExample)
CA (1) CA2947252C (enExample)
ES (1) ES2915909T3 (enExample)
PL (1) PL3137067T3 (enExample)
WO (1) WO2015166463A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100041621A1 (en) * 2008-08-15 2010-02-18 Perry Renshaw Methods and compositions for improving cognitive performance
US11583546B2 (en) 2014-04-30 2023-02-21 Kyowa Hakko Bio Co., Ltd. Administration of citicoline to improve cognitive performance, attentional performance, and motor function

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020198172A1 (en) * 1997-12-01 2002-12-26 Sandage Bobby W. Method of treating motor neuron diseases and demyelinating diseases with citicoline
US20070004670A1 (en) * 1998-07-31 2007-01-04 Richard Wurtman Compositions containing citicoline, and methods of use thereof
US20030114415A1 (en) * 2001-12-14 2003-06-19 Wurtman Richard J. Compositions and methods for treating and preventing memory impairment using citicoline
EP1604671A4 (en) * 2003-02-26 2006-03-29 Kyowa Hakko Kogyo Kk MUSCLE TREATMENT AND MEANS FOR PREVENTING OR TREATING MUSCLE WEAKNESS
US20070248696A1 (en) * 2006-04-25 2007-10-25 Mind Sports Nutrition Inc. Composition and method for enhancing neuromuscular facilitation and cognitive functions
US20100041620A1 (en) * 2008-08-15 2010-02-18 Perry Renshaw Methods for improving frontal brain bioenergetic metabolism
US20100041621A1 (en) * 2008-08-15 2010-02-18 Perry Renshaw Methods and compositions for improving cognitive performance
EP2914270B1 (en) 2012-10-30 2022-01-12 Kyowa Hakko Bio Co., Ltd. Agent for preventing or improving decline in brain function
US9883831B1 (en) * 2014-01-30 2018-02-06 Texas Health Biomedical Advancement Center, Inc. Digital medical evaluation and testing on a touch screen device
US11583546B2 (en) 2014-04-30 2023-02-21 Kyowa Hakko Bio Co., Ltd. Administration of citicoline to improve cognitive performance, attentional performance, and motor function

Also Published As

Publication number Publication date
US12115181B2 (en) 2024-10-15
CA2947252A1 (en) 2015-11-05
CA2947252C (en) 2022-05-10
US20230181614A1 (en) 2023-06-15
JP6584430B2 (ja) 2019-10-02
AU2015254865B2 (en) 2020-07-02
EP3137067A4 (en) 2017-12-27
JP2017520513A (ja) 2017-07-27
EP3137067A1 (en) 2017-03-08
NZ725643A (en) 2021-08-27
EP3137067B1 (en) 2022-05-04
WO2015166463A1 (en) 2015-11-05
AU2015254865A1 (en) 2016-11-24
ES2915909T3 (es) 2022-06-27
US11583546B2 (en) 2023-02-21
US20170049796A1 (en) 2017-02-23

Similar Documents

Publication Publication Date Title
EP2995532A4 (en) VEHICLE
AU359765S (en) Bus
AU358957S (en) Vehicle
AU356990S (en) Vehicle
AP2015008938A0 (en) Vehicle
AP2015008940A0 (en) Vehicle
PT3154853T (pt) Máquina motriz fora de borda
SG11201608628WA (en) Propulsion unit
PL3125411T3 (pl) Ulepszona konstrukcja silnika
GB201404026D0 (en) iImprovements relating to vehicle seating
GB2538045B (en) Improvements to letter-plates
ZA201506430B (en) Utility vehicle
GB2529835B (en) Utility vehicle
PT3176022T (pt) Autocarro
GB201501701D0 (en) Motor
EP2982582A4 (en) VEHICLE
GB2550166B (en) Improvements to letter-plates
GB2522473B (en) Improvements to windposts
GB201407560D0 (en) Improvements to radiator apparatuses
GB201417276D0 (en) Improved vehicle
GB2520781B (en) Improvements to hydro-turbines
GB201521028D0 (en) Improvements to Li-fi
IL230674A0 (en) Account management for employees
GB201416387D0 (en) Tempory it was PIN-SEC pleace change to PIN-SAFE
GB201414608D0 (en) Improvements to structure